Different expression of GSK3β and pS9GSK3β depending on phenotype of cervical cancer: possible association of GSK3β with squamous cell carcinoma and pS9GSK3β with adenocarcinoma

키워드

참고문헌 (34)

1. Wang SS, "Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976–2000", Cancer, 100, pp.1035~1044 (2004)
2. Green J, "Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20–44 years : the UK National Case-Control Study of Cervical Cancer", Br J Cancer, 89, pp.2078~2086 (2003)
3. Bertelsen BI, "Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia : frequent PIK3CA amplification and AKT phosphorylation", Int J Cancer, 118, pp.1877~1883 (2006)
4. Pett MR, "Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes", Cancer Res, 64, pp.1359~1368 (2004)
5. Duensing S, "Centrosomes, genomic instability, and cervical carcinogenesis", Crit Rev Eukaryot Gene Expr, 13, pp.9~23 (2003)
6. Manzo-Merino J, "The role of signaling pathways in cervical cancer and molecular therapeutic targets", Arch Med Res, 45, pp.525~539 (2014)
7. Doble BW, "GSK-3 : tricks of the trade for a multi-tasking kinase", J Cell Sci, 116, pp.1175~1186 (2003)
8. Mishra R, "Glycogen synthase kinase 3 beta : can it be a target for oral cancer", Mol Cancer, 9, pp.144~ (2010)
9. Rath G, "Clinical significance of inactivated glycogen synthase kinase 3β in HPV-associated cervical cancer : relationship with Wnt", β-catenin pathway activation, 2015, pp.73, 460~478
10. Shakoori A, "Deregulated GSK3beta activity in colorectal cancer : its association with tumor cell survival and proliferation", Biochem Biophys Res Commun, 334, pp.1365~1373 (2005)
11. Zheng H, "Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas", Anticancer Res, 27, pp.3561~3569 (2007)
12. Mishra R, "Expression and inactivation of glycogen synthase kinase 3 alpha", beta and their association with the expression of cyclin D1 and p53 in oral squamous cell carcinoma progression, 2015, pp.14, 20~
13. 박현수, "Glycogen synthase kinase 3β and cyclin D1 expression in cervical carcinogenesis", Obstetrics & Gynecology Science, 59(6), pp.470~478 (2016), 대한산부인과학회[DOI]
14. Klaes R, "Overexpression of p16(INK4A)as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri", Int J Cancer, 92, pp.276~284 (2001)
15. Lee H, "Differential expression of GSK3β and pS9GSK3β in normal human tissues : can pS9GSK3β be an epithelial marker", Int J Clin Exp Pathol, 8, pp.4064~4073 (2015)
16. Gao C, "FAK", PYK2 promotes the Wnt, ELife, pp.2015, 4[DOI]
17. Darragh TM, "The lower anogenital squamous terminology standardization project for HPV-associated lesions : background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology", J Low Genit Tract Dis, 16, pp.205~242 (2012)
18. Eun-Kyoung Yim, "The Role of HPV E6 and E7 Oncoproteins in HPV-associated Cervical Carcinogenesis", Cancer Research and Treatment, 37(6), pp.319~324 (2005), 대한암학회
19. Bello JO, "Regulation of the Wnt", β-catenin signaling pathway by human papillomavirus E6 and E7 oncoproteins, 2015, pp.7, 4734~4755
20. Zhang L, "The role of the PI3K", Akt, Mol Cancer, pp.2015, 14[DOI]
21. Choi SK, "Overexpression of PI3K-p110α in the progression of uterine cervical neoplasia and its correlation with pAkt and DJ-1", Eur J Gynaecol Oncol, 36, pp.389~393 (2015)
22. Leis H, "Expression, localization, and activity of glycogen synthase kinase 3beta during mouse skin tumorigenesis", Mol Carcinog, 35, pp.180~185 (2002)
23. Pérez-Plasencia C, "Genome wide expression analysis in HPV16 cervical cancer : identification of altered metabolic pathways", Infect Agent Cancer, 2, pp.16~ (2007)
24. Ng SS, "Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade", J Biol Chem, 284, pp.35308~35313 (2009)
25. Naito S, "Glycogen synthase kinase-3beta : a prognostic marker and a potential therapeutic target in human bladder cancer", Clin Cancer Res, 16, pp.5124~5132 (2010)
26. Ougolkov AV, "Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer : association with kinase activity and tumor dedifferentiation", Clin Cancer Res, 12, pp.5074~5081 (2006)
27. Ougolkov AV, "Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells", Cancer Res, 65, pp.2076~2081 (2005)
28. Beurel E, "The paradoxical pro-and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways", Prog Neurobiol, 79, pp.173~189 (2006)
29. Cole A, "Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3(GSK3)in mammalian cells is an autophosphorylation event", Biochem J, 377, pp.249~255 (2004)
30. Beurel E, "Glycogen synthase kinase-3(GSK3) : regulation, actions, and diseases", Pharmacol Ther, 148, pp.114~131 (2015)
31. Jope RS, "The glamour and gloom of glycogen synthase kinase-3", Trends Biochem Sci, 29, pp.95~102 (2004)
32. Zhou FQ, "NGFinduced axon growth is mediated by localized inactiva tion of GSK-3beta and functions of the microtubule plus end binding protein APC", Neuron, 42, pp.897~912 (2004)
33. Xu W, "Glycogen synthase kinase 3β orchestrates microtubule remodeling in compensatory glomerular adaptation to podocyte depletion", J Biol Chem, 290, pp.1348~1363 (2015)
34. Debnath J, "Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner", J Cell Biol, 163, pp.315~326 (2003)

관련 논문AI추천